Jones Financial Companies
IRMD icon

Jones Financial Companies’s iRadimed IRMD Stock Holding History

Jones Financial Companies’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.4K Sell
723
-90
-11% -$9K ﹤0.01% 2816
2025
Q4 		$79.1K Sell
813
-30
-4% -$2.57K ﹤0.01% 2305
2025
Q3 		$59.2K Sell
843
-50
-6% -$3.33K ﹤0.01% 2300
2025
Q2 		$54.3K Buy
893
+44
+5% +$2.41K ﹤0.01% 2195
2025
Q1 		$44.5K Buy
849
+719
+553% +$40.4K ﹤0.01% 2110
2024
Q4 		$7.15K Buy
+130
New +$6.84K ﹤0.01% 2650

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jones Financial Companies's IRMD Position: Q1 2026 in Review

Jones Financial Companies reduced its iRadimed (IRMD) stake by 11% in Q1 2026, selling an estimated $9K and leaving 723 shares worth $70.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2816.

Jones Financial Companies first reported a position in IRMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $79.1K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Jones Financial Companies held 723 shares of iRadimed worth $70.4K as of Q1 2026.
  • Jones Financial Companies sold 90 iRadimed shares in Q1 2026, an estimated $9K.
  • iRadimed made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2816 holding.
  • Jones Financial Companies first reported a position in iRadimed in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's iRadimed position peaked at $79.1K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.